Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

26.55
-1.9300-6.78%
Volume:2.88M
Turnover:78.48M
Market Cap:2.15B
PE:-5.80
High:28.06
Open:28.03
Low:25.82
Close:28.48
Loading ...

Beam Therapeutics Q4 EPS USD -1.09 VS. Ibes Estimate USD -1.2

THOMSON REUTERS
·
25 Feb

Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts

GlobeNewswire
·
25 Feb

AI Biotech Stocks Tumbled, with HIMS Plunging 17% and TEM Slumping 15%

Tiger Newspress
·
25 Feb

Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences

GlobeNewswire
·
24 Feb

Why Beam Therapeutics Inc. (BEAM) is the Best Performing Pharma Stock So Far in 2025

Insider Monkey
·
24 Feb

Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
21 Feb

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks
·
18 Feb

Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?

Zacks
·
10 Feb

Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Feb

Beam Therapeutics Inc.'s (NASDAQ:BEAM) Prospects Need A Boost To Lift Shares

Simply Wall St.
·
31 Jan

Investors in Beam Therapeutics (NASDAQ:BEAM) from three years ago are still down 55%, even after 3.8% gain this past week

Simply Wall St.
·
31 Jan

Beam Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald

Dow Jones
·
29 Jan

Cantor Fitzgerald Upgrades Beam Therapeutics to Overweight From Neutral

MT Newswires Live
·
29 Jan

Wall Street Analysts Think Beam Therapeutics (BEAM) Could Surge 84.45%: Read This Before Placing a Bet

Zacks
·
28 Jan

Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

Zacks
·
24 Jan

Positive Report for Beam Therapeutics (BEAM) from Bernstein

TIPRANKS
·
24 Jan